Propanc Biopharma Inc (PPCB)

May 22, 2026

PPCB Should I Buy - Intellectia AI

May 22, 2026

May 21, 2026

Propanc Biopharma (PPCB) Earnings Outlook: Key Metrics for Q3 2025Post-Announcement Reaction - Newser

May 21, 2026

May 21, 2026

PPCB Stock Price, Quote & Chart | PROPANC BIOPHARMA INC (NASDAQ:PPCB) - ChartMill

May 21, 2026

May 20, 2026

Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade - The Manila Times

May 20, 2026

May 20, 2026

Propanc Biopharma to file CTA in Australia for phase 1b study in 30-40 advanced cancer patients - marketscreener.com

May 20, 2026

May 20, 2026

Propanc Biopharma, Inc. CEO Forecasts Medical Breakthroughs Against Pancreatic Cancer Over Next Decade - Quiver Quantitative

May 20, 2026

May 20, 2026

Propanc pancreatic cancer drug saw 3 of 4 patients outlive life expectancy - Stock Titan

May 20, 2026

May 19, 2026

Propanc engages CDMO for GMP manufacture of cancer drug PRP By Investing.com - Investing.com Australia

May 19, 2026

May 19, 2026

Propanc engages CDMO for GMP manufacture of cancer drug PRP - Investing.com UK

May 19, 2026

May 19, 2026

Propanc Biopharma engages European CDMO for GMP production of PRP - TipRanks

May 19, 2026

May 19, 2026

Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 3040 Advanced Cancer Patients - The Manila Times

May 19, 2026

May 19, 2026

Once-weekly proenzyme cancer therapy nears first tests in humans - Stock Titan

May 19, 2026

May 18, 2026

Propanc Biopharma (PPCB) Stock: Up +21.18%, Key Resistance at $2.16 2026-05-18Sector Analysis - newser.com

May 18, 2026

May 15, 2026

Propanc Biopharma reports Q3 results, secures financing - Investing.com UK

May 15, 2026

May 15, 2026

Propanc Biopharma reports Q3 results, secures financing By Investing.com - Investing.com Nigeria

May 15, 2026

May 15, 2026

Propanc Biopharma, Inc. Reports Q3 Financial Results and Key Corporate Developments - Quiver Quantitative

May 15, 2026

May 15, 2026

Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results - marketscreener.com

May 15, 2026

May 15, 2026

Propanc moves to world-first cancer trial and anti-aging research - Stock Titan

May 15, 2026

May 14, 2026

Propanc Biopharma, Inc. 3Q 2026: Revenue $0 Net loss $(6.36M), EPS $(0.28) — 10-Q Summary - TradingView

May 14, 2026

May 14, 2026

Propanc Biopharma (PPCB) posts Q3 2026 loss and flags going concern risk - Stock Titan

May 14, 2026

May 14, 2026

Propanc Biopharma to Implement 1-for-25 Reverse Stock Split >PPCB - Moomoo

May 14, 2026

May 14, 2026

Propanc Biopharma announces 1-for-25 reverse stock split By Investing.com - Investing.com Australia

May 14, 2026

May 14, 2026

25 Propanc shares become 1 in Nasdaq bid-price compliance move - Stock Titan

May 14, 2026

May 13, 2026

Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans - The Manila Times

May 13, 2026

May 13, 2026

Propanc Biopharma announces 1-for-25 reverse stock split - Investing.com

May 13, 2026

May 13, 2026

Propanc Biopharma, Inc. Announces 1-for-25 Reverse Stock Split to Enhance Nasdaq Compliance - Quiver Quantitative

May 13, 2026

May 13, 2026

Propanc Biopharma implements reverse stock split to support continued Nasdaq listing and growth plans - marketscreener.com

May 13, 2026

May 08, 2026

The supply chain story behind Propanc Biopharma (PPCB) earnings |Crowd Trend Signals - newser.com

May 08, 2026

Apr 27, 2026

Propanc Biopharma announces up to $100M strategic financing from Hexstone Capital - MSN

Apr 27, 2026

Apr 21, 2026

[EFFECT] Propanc Biopharma, Inc. SEC Filing - Stock Titan

Apr 21, 2026

Apr 19, 2026

Trending Industry Today: Propanc Biopharma Leads Gains In ETH-Holding Companies Stocks - Moomoo

Apr 19, 2026

Apr 17, 2026

Rosen Law Firm Encourages Propanc Biopharma Inc. Investors to Inquire About Securities Class Action Investigation – PPCB - The Joplin Globe

Apr 17, 2026

Apr 15, 2026

12 Health Care Stocks Moving In Wednesday's Intraday SessionAspire Biopharma Holdings (NASDAQ:ASBP), H - Benzinga

Apr 15, 2026

Apr 10, 2026

Propanc Biopharma Incfiles to offer resale of up to 15 million shares of common stock by selling stockholderSEC filing - marketscreener.com

Apr 10, 2026

Apr 10, 2026

Propanc Biopharma (PPCB) files S-1 for 15M-share resale from Series C preferred - Stock Titan

Apr 10, 2026

Apr 09, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 09, 2026

Apr 01, 2026

PPCB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Propanc Biopharma (PPCB) approves restricted grants, reverse split 1:10–1:30 - Stock Titan

Mar 31, 2026

Mar 28, 2026

Propanc Biopharma, Inc. (PPCB) - Minichart

Mar 28, 2026

Mar 28, 2026

What should investors watch in Propanc Biopharma (PPCB) Stock | Price at $0.10, Down 3.30%Buy Signals - Newser

Mar 28, 2026

Mar 24, 2026

Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain - BioSpace

Mar 24, 2026

Mar 24, 2026

Propanc extends 17-year Spain research tie to study aging and cancer - Stock Titan

Mar 24, 2026

Mar 24, 2026

Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer - GlobeNewswire

Mar 24, 2026